Atlas Trials

Refractory Anemia With Ringed Sideroblasts

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Anemia With Ringed Sideroblasts

RecordFirmDate
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies (NCT01789255)National Cancer Institute (NCI)2013-06-01
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies (NCT01384513)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2011-08-04
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT (NCT01012492)Boston Children's Hospital2009-11-01
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01146210)Children's Oncology Group2009-05-01
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia (NCT00462605)National Cancer Institute (NCI)2007-04-01
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes (NCT00104962)National Cancer Institute (NCI)2005-03-01
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858)Fred Hutchinson Cancer Center2003-09-01
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00119366)Fred Hutchinson Cancer Center2003-05-01
Tipifarnib in Treating Patients With Myelodysplastic Syndromes (NCT00005845)National Cancer Institute (NCI)2002-06-01
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00027820)Fred Hutchinson Cancer Center2001-08-01
Thalidomide in Treating Patients With Myelodysplastic Syndrome (NCT00015990)National Cancer Institute (NCI)2001-04-01
Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT00008177)Fred Hutchinson Cancer Center1999-07-27
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00002798)National Cancer Institute (NCI)1996-08-01

Track Refractory Anemia With Ringed Sideroblasts automatically

Every clearance here is in the API, with alerts when new ones post.